Status:

UNKNOWN

Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Vancomycin Resistant Enterococcus Intestinal Carriage

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 w...

Detailed Description

This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 w...

Eligibility Criteria

Inclusion

  • Age \>18;
  • Vancomycin Resistant Enterococcus intestinal carriage

Exclusion

  • Neutropenia \<1000 /mm3,
  • Immunosuppressive drugs,
  • Inhalation

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2009

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00437580

Start Date

February 1 2007

End Date

August 1 2009

Last Update

January 19 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service des Maladies infectieuses et tropicales

Hôpital Gabriel Montpied, Clermont-Ferrand, France, 63003

Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage | DecenTrialz